| Detected | Trial | Change |
|---|---|---|
| 2026-06-05 | NCT05741164 Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With… |
Recruitment opened |
| 2026-06-05 | NCT05741164 Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With… |
date change Completion pushed: 2028-11-30 -> 2029-06-30 |
| 2026-05-23 | NCT06972056 Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study |
Trial sites expanded: 23 -> 35 locations |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05997732 | Sympathetic Neurovascular Transduction: Role of Adrenergic Receptors and Sex Differences | Vasoconstriction | Recruiting |
| NCT05786417 | LIVEBETTER: A Trial Comparing Medications in Older Adults With Stable Angina and Multiple… | Angina | Recruiting |
| NCT05587361 | Beta-Adrenergic Modulation of Drug Cue Reactivity | Tobacco Use Disorder | Recruiting |
| NCT05853627 | Mismatch vs. Standard Intervention During Memory Reconsolidation Blockade With… | Stress Disorders, Post-Traumatic | Recruiting |
| NCT06982183 | The Effects of Propranolol and Hydrocortisone on Military-Relevant Performance Outcomes | Fear of Spiders | Recruiting |
| NCT06972056 | Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study | Migraine | Recruiting |
| NCT07352228 | Carvedilol vs. Propranolol for Preventing Rebleeding After Endoscopic Treatment of… | Rebleeding of Portal Hypertension in Liver Cirrhosis | Enrolling by Invitation |
| NCT07583134 | Impact of Propranolol Strategies on Myocardial Injury After Breast Cancer Surgery | Breast Cancer | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT06798363 | Efficacy and Safety of Different Initial Doses of Oral Propranolol in the Treatment of… | Infantile Hemangioma | Recruiting |
| Phase 2 | |||
| NCT04682158 | Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma | Esophageal Adenocarcinoma | Recruiting |
| NCT07091279 | Propranolol for Aggression, Self-Injury, and Severe Disruptive Behavior in Adolescents… | Autism Spectrum Disorder | Recruiting |
| NCT06445166 | Propranolol for the Treatment of Kaposi Sarcoma in Adults | Kaposi Sarcoma | Recruiting |
| NCT03083431 | Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity | Retinopathy of Prematurity | Recruiting |
| NCT05741164 | Propranolol and Pembrolizumab for Tumor Re-sensitization and Treatment of Patients With… | Anatomic Stage III Breast Cancer AJCC v8 | Recruiting |
| NCT05797662 | A Study of Propranolol to Treat Kaposi Sarcoma | Kaposi Sarcoma | Not Yet Recruiting |
| NCT04848519 | Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With… | Locally Advanced Bladder Urothelial Carcinoma | Active, Not Recruiting |
| NCT07452978 | Propranolol for Early Secondary Prevention of Post-Traumatic Stress Disorder in Women… | PTSD - Post Traumatic Stress Disorder | Not Yet Recruiting |
| NCT07549906 | Neoadjuvant Iparomlimab/Tuvonralimab Plus CAPEOX Versus Iparomlimab/Tuvonralimab Plus… | Colon Cancer (Stage II &Amp; III) | Not Yet Recruiting |
| NCT06120140 | Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor… | Carcinoma, Non-Small-Cell Lung | Active, Not Recruiting |
| Phase 1 | |||
| NCT07353294 | Propranolol With Tislelizumab Plus GC in Neoadjuvant Bladder UC | Bladder Urothelial Carcinoma | Enrolling by Invitation |
| Early Phase 1 | |||
| NCT01988883 | Modafinil and Cognitive Function in POTS | Postural Tachycardia Syndrome | Active, Not Recruiting |
| Not specified | |||
| NCT07354126 | Comparative Efficacy of Flunarizine and Propanolol in Pediatric Migraine | Migraine | Recruiting |
| NCT07099677 | Short-Term Effects of Antihypertensive Drugs on Postural Balance and Fall Risk | Hypertension | Recruiting |
| NCT05429970 | A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer… | Ovarian Cancer | Recruiting |
| NCT07568574 | Impact of Medically Supervised Performance-Enhancing Substances (PES) on Elite Athletes | Safety and Impact of Medically Supervised Performance Enhancing Substance Usage in Healthy Elite Athletes | Enrolling by Invitation |